EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human brain effects of DMT assessed via EEG-fMRI

Christopher Timmermann iD, Leor Roseman, Sharad Haridas, Fernando E Rosas iD, Lisa Luan, Hannes Kettner, Jonny Martell iD, David Erritzoe iD, Enzo Tagliazucchi, Carla Pallavicini, Manesh Girn, Andrea Alamia iD und 3 weitere

Proceedings of the National Academy of Sciences · 28.03.2023 · 120 (13)

DOI: 10.1073/pnas.2218949120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.03.2023. Verfasst von Christopher Timmermann und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, W12 0NN London, UK. Hauptthemen laut MEDLINE: N,N-Dimethyltryptamine, Hallucinogens. Die Arbeit wurde bisher 227-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANID | Fondo Nacional de Desarrollo Científico y Tecnológico, Funding funders for the Centre for Psychedelic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelics have attracted medical interest, but their effects on human brain function are incompletely understood. In a comprehensive, within-subjects, placebo-controlled design, we acquired multimodal neuroimaging [i.e., EEG-fMRI (electroencephalography-functional MRI)] data to assess the effects of intravenous (IV) N,N-Dimethyltryptamine (DMT) on brain function in 20 healthy volunteers. Simultaneous EEG-fMRI was acquired prior to, during, and after a bolus IV administration of 20 mg DMT, and, separately, placebo. At dosages consistent with the present study, DMT, a serotonin 2A receptor (5-HT2AR) agonist, induces a deeply immersive and radically altered state of consciousness. DMT is thus a useful research tool for probing the neural correlates of conscious experience. Here, fMRI results revealed robust increases in global functional connectivity (GFC), network disintegration and desegregation, and a compression of the principal cortical gradient under DMT. GFC × subjective intensity maps correlated with independent positron emission tomography (PET)-derived 5-HT2AR maps, and both overlapped with meta-analytical data implying human-specific psychological functions. Changes in major EEG-measured neurophysiological properties correlated with specific changes in various fMRI metrics, enriching our understanding of the neural basis of DMT’s effects. The present findings advance on previous work by confirming a predominant action of DMT—and likely other 5-HT2AR agonist psychedelics—on the brain’s transmodal association pole, i.e., the neurodevelopmentally and evolutionarily recent cortex that is associated with species-specific psychological advancements, and high expression of 5-HT2A receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N,N-DimethyltryptamineHallucinogensHumansMagnetic Resonance ImagingBrainElectroencephalography

Stichwörter der Autor:innen

ayahuascaconsciousnessdimethyltryptaminepsychedelicsserotonin

Substanzen

N,N-DimethyltryptamineHallucinogens

Autor:innen und Institutionen

  • Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, W12 0NN London, UK.
  • Department of Informatics, University of Sussex, Brighton BN1 9RH, United Kingdom.
  • Centre for Complexity Science, Imperial College London, London SW7 2AZ, United Kingdom.
  • Center for Eudaimonia and Human Flourishing, University of Oxford, Oxford OX3 9BX, United Kingdom.
  • Departamento de Física, Latin American Brain Health Institute, Universidad Adolfo Ibanez, 3485 Santiago, Chile.
  • Universidad de Buenos Aires and Instituto de Física de Buenos Aires, 1428 Buenos Aires, Argentina.

ORCID-Profile: Christopher Timmermann, Fernando E Rosas, Jonny Martell, David Erritzoe, Andrea Alamia, Robert Leech, David J Nutt

Förderung

  • ANID | Fondo Nacional de Desarrollo Científico y Tecnológico
  • Funding funders for the Centre for Psychedelic Research

Zitieren

APA

Timmermann, C., Roseman, L., Haridas, S., Rosas, F. E., Luan, L., Kettner, H., Martell, J., Erritzoe, D., Tagliazucchi, E., Pallavicini, C., Girn, M., Alamia, A., Leech, R., Nutt, D. J., & Carhart-Harris, R. L. (2023). Human brain effects of DMT assessed via EEG-fMRI. Proceedings of the National Academy of Sciences, 120(13). https://doi.org/10.1073/pnas.2218949120

Vancouver

Timmermann C, Roseman L, Haridas S, Rosas FE, Luan L, Kettner H, et al. Human brain effects of DMT assessed via EEG-fMRI. Proceedings of the National Academy of Sciences. 2023;120(13). doi:10.1073/pnas.2218949120

BibTeX
@article{Timmermann2023,
  author = {Timmermann, Christopher and Roseman, Leor and Haridas, Sharad and Rosas, Fernando E and Luan, Lisa and Kettner, Hannes and Martell, Jonny and Erritzoe, David and Tagliazucchi, Enzo and Pallavicini, Carla and Girn, Manesh and Alamia, Andrea and Leech, Robert and Nutt, David J and Carhart-Harris, Robin L},
  title = {Human brain effects of DMT assessed via EEG-fMRI},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {13},
  doi = {10.1073/pnas.2218949120}
}
Kostenlos starten →